Sundrug Co Ltd
TSE:9989
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
3 440
4 890
|
| Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Sundrug Co Ltd
Sundrug Co Ltd
Net Income (Common)
Sundrug Co Ltd
Net Income (Common) Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sundrug Co Ltd
TSE:9989
|
Net Income (Common)
¥29.5B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
|
Tsuruha Holdings Inc
TSE:3391
|
Net Income (Common)
¥24.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
5%
|
|
|
Welcia Holdings Co Ltd
TSE:3141
|
Net Income (Common)
¥21.9B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
3%
|
CAGR 10-Years
11%
|
|
|
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Net Income (Common)
¥24.8B
|
CAGR 3-Years
10%
|
CAGR 5-Years
5%
|
CAGR 10-Years
7%
|
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Net Income (Common)
¥52B
|
CAGR 3-Years
32%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
|
Cosmos Pharmaceutical Corp
TSE:3349
|
Net Income (Common)
¥26.1B
|
CAGR 3-Years
0%
|
CAGR 5-Years
6%
|
CAGR 10-Years
10%
|
|
Sundrug Co Ltd
Glance View
Sundrug Co., Ltd. engages in the pharmaceutical business. The company is headquartered in Fuchu-Shi, Tokyo-To and currently employs 5,634 full-time employees. The Drug Store segment is primarily engaged in the sale of pharmaceutical products, cosmetic products and sundry goods, among others. The Discount Store segment is primarily engaged in the sale of foodstuffs, household sundry goods, among others.
See Also
What is Sundrug Co Ltd's Net Income (Common)?
Net Income (Common)
29.5B
JPY
Based on the financial report for Jun 30, 2024, Sundrug Co Ltd's Net Income (Common) amounts to 29.5B JPY.
What is Sundrug Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
7%
Over the last year, the Net Income (Common) growth was 12%. The average annual Net Income (Common) growth rates for Sundrug Co Ltd have been 6% over the past three years , 4% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
